• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用DOTA修饰蛋白质的简便、水溶性方法。利用高温和优化的pH值在放射性标记免疫缀合物中实现高比活性和高螯合物稳定性。

A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.

作者信息

Lewis M R, Raubitschek A, Shively J E

机构信息

Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California 91010.

出版信息

Bioconjug Chem. 1994 Nov-Dec;5(6):565-76. doi: 10.1021/bc00030a012.

DOI:10.1021/bc00030a012
PMID:7873659
Abstract

We have developed a method for attachment of the macrocyclic chelating agent 1,4,7,10-tetraazacyclododecane N,N',N",N"'-tetraacetic acid (DOTA) to proteins by activation of a single carboxyl group with N-hydroxysulfosuccinimide (sulfo-NHS). The sulfo-NHS active ester of DOTA was prepared in a single step using 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC), and DOTA conjugates of cytochrome c and the anti-carcinoembryonic antigen chimeric monoclonal antibody cT84.66 were prepared by adding the DOTA active ester reaction mixture to the proteins at pH 8.5-9.0. Mass spectrometry of the cytochrome c conjugates showed that as the molar ratio of DOTA active ester to protein in the reaction mixture was increased from 10:1 to 100:1, the average number of chelators attached to the protein molecule increased from 2.64 to 8.79. When DOTA active ester reacted with the antibody at a molar ratio of 100:1, the conjugate averaged 3.8 chelates per antibody. Immunoreactivity of the antibody conjugate radiolabeled with 111In(III) and 90Y(III) remained quantitative. Variation of the DOTA:sulfo-NHS:EDC activation stoichiometry from 2:2:1 to 10:10:1 revealed that the kinetic stability of the radioconjugates increased as the molar ratio of carbodiimide, relative to DOTA and sulfo-NHS, was decreased. Radiolabeling of the protein conjugates with 111In(III) and 90Y(III) proved to be sensitive to pH, buffer, and temperature effects. The optimum pH for the labeling reaction was different for each protein and may be related to the isoelectric point of the protein. Radiometal incorporation at high specific activity was accomplished in acetate and Tris buffers, but the presence of citrate inhibited the labeling reaction. Increasing the temperature of the radiolabeling reaction from 25 to 43 degrees C greatly increased both the efficiency of radiometal incorporation and the kinetic stability of the radioconjugates. Stability studies of the conjugates in human serum and in the presence of a 5000- to 250,000-fold excess of diethylenetriaminepentaacetic acid (DTPA) demonstrated that the radiolabeled proteins are kinetically inert under physiological conditions. In serum, the 111In(III)-labeled antibody showed a rate of radiometal loss of approximately 0.08% per day. In the presence of excess DTPA, both conjugates lost 111In(III) at a rate of about 0.3% per day. No loss of 90Y(III) from the conjugates was observed in serum, but in excess DTPA, both 90Y(III) labeled proteins showed a rate of radiometal loss of approximately 0.2% per day. Therefore, kinetic analysis of metal loss from a radiolabeled immunoconjugate in the presence of a vast excess of DTPA may provide a better indication of the in vivo stability of that immunoconjugate than serum stability studies.

摘要

我们开发了一种通过用N-羟基磺基琥珀酰亚胺(磺基-NHS)活化单个羧基将大环螯合剂1,4,7,10-四氮杂环十二烷N,N',N",N"'-四乙酸(DOTA)连接到蛋白质上的方法。使用1-乙基-3-[3-(二甲氨基)丙基]碳二亚胺(EDC)一步制备DOTA的磺基-NHS活性酯,并通过在pH 8.5-9.0下将DOTA活性酯反应混合物加入蛋白质中来制备细胞色素c和抗癌胚抗原嵌合单克隆抗体cT84.66的DOTA缀合物。细胞色素c缀合物的质谱分析表明,随着反应混合物中DOTA活性酯与蛋白质的摩尔比从10:1增加到100:1,连接到蛋白质分子上的螯合剂平均数量从2.64增加到8.79。当DOTA活性酯与抗体以100:1的摩尔比反应时,缀合物平均每个抗体有3.8个螯合物。用111In(III)和90Y(III)放射性标记的抗体缀合物的免疫反应性保持定量。将DOTA:磺基-NHS:EDC活化化学计量比从2:2:1改变为10:10:1表明,随着碳二亚胺相对于DOTA和磺基-NHS的摩尔比降低,放射性缀合物的动力学稳定性增加。用111In(III)和90Y(III)对蛋白质缀合物进行放射性标记被证明对pH、缓冲液和温度效应敏感。标记反应的最佳pH因每种蛋白质而异,可能与蛋白质的等电点有关。在乙酸盐和Tris缓冲液中实现了高比活度的放射性金属掺入,但柠檬酸盐的存在会抑制标记反应。将放射性标记反应的温度从25℃提高到43℃大大提高了放射性金属掺入效率和放射性缀合物的动力学稳定性。在人血清中以及在存在5000至250,000倍过量二乙烯三胺五乙酸(DTPA)的情况下对缀合物进行的稳定性研究表明,放射性标记的蛋白质在生理条件下是动力学惰性的。在血清中,111In(III)标记的抗体显示放射性金属损失率约为每天0.08%。在过量DTPA存在下,两种缀合物以约每天0.3%的速率损失111In(III)。在血清中未观察到缀合物中90Y(III)的损失,但在过量DTPA中,两种90Y(III)标记的蛋白质显示放射性金属损失率约为每天0.2%。因此,在大量过量DTPA存在下对放射性标记免疫缀合物中金属损失的动力学分析可能比血清稳定性研究更好地表明该免疫缀合物的体内稳定性。

相似文献

1
A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.一种用DOTA修饰蛋白质的简便、水溶性方法。利用高温和优化的pH值在放射性标记免疫缀合物中实现高比活性和高螯合物稳定性。
Bioconjug Chem. 1994 Nov-Dec;5(6):565-76. doi: 10.1021/bc00030a012.
2
Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.马来酰亚胺半胱氨酸酰胺 - DOTA衍生物:用于将放射性金属螯合物与抗体巯基结合的新型试剂会发生pH依赖性裂解反应。
Bioconjug Chem. 1998 Jan-Feb;9(1):72-86. doi: 10.1021/bc970136v.
3
Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.钇-90-DOTA免疫缀合物螯合的优化条件。
J Nucl Med. 1998 Dec;39(12):2105-10.
4
Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems.111铟和90钇标记的与嵌合抗癌胚抗原抗体偶联的DOTA及马来酰亚胺基半胱氨酸酰胺基-DOTA在荷瘤裸鼠体内的生物分布:稳定和化学不稳定连接体系统的比较
Bioconjug Chem. 1998 Jan-Feb;9(1):87-93. doi: 10.1021/bc970137n.
5
90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.90Y-多胺基多羧基大环配体-人源化抗CD19单克隆抗体:一种用于非霍奇金淋巴瘤放射免疫治疗的药物。
J Nucl Med. 2003 Jan;44(1):77-84.
6
Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies.三功能偶联试剂。含有生物素和放射性金属螯合部分的试剂,用于体外亲和吸附放射性标记抗体。
Bioconjug Chem. 2002 Sep-Oct;13(5):1079-92. doi: 10.1021/bc025535r.
7
An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA.一种将单克隆抗体与N-羟基琥珀酰亚胺基DOTA偶联的改进方法。
Bioconjug Chem. 2001 Mar-Apr;12(2):320-4. doi: 10.1021/bc0000886.
8
Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with ⁹⁰Y and ¹¹¹In for domestic radioimmunotherapy and radioscintigraphy of non-Hodgkin's lymphoma.制备并冻干(试剂盒)形式的 DOTA-利妥昔单抗,并用 ⁹⁰Y 和 ¹¹¹In 进行标记,用于非霍奇金淋巴瘤的国内放射性免疫治疗和放射闪烁显像。
Daru. 2014 Jul 29;22(1):58. doi: 10.1186/2008-2231-22-58.
9
Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method.用钇-90和铟-111-DOTA螯合物标记单克隆抗体:一种简单有效的方法。
Bioconjug Chem. 1994 Mar-Apr;5(2):101-4. doi: 10.1021/bc00026a001.
10
Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.比较(64)Cu 络合双功能螯合剂用于放射性免疫缀合:标记效率、比活度和体外/体内稳定性。
Bioconjug Chem. 2012 May 16;23(5):1029-39. doi: 10.1021/bc300037w. Epub 2012 Apr 13.

引用本文的文献

1
Recent Advances in Polymers Bearing Activated Esters for the Synthesis of Glycopolymers by Postpolymerization Modification.通过后聚合改性合成糖聚合物的含活化酯聚合物的最新进展
Polymers (Basel). 2024 Apr 15;16(8):1100. doi: 10.3390/polym16081100.
2
A Kinetically Controlled Bioconjugation Method for the Synthesis of Radioimmunoconjugates and the Development of a Domain Mapping MS-Workflow for Its Characterization.一种动力学控制的生物偶联方法,用于放射性免疫偶联物的合成,以及开发用于其表征的域映射 MS 工作流程。
Bioconjug Chem. 2024 Mar 20;35(3):324-332. doi: 10.1021/acs.bioconjchem.3c00519. Epub 2024 Feb 17.
3
Enhanced Therapeutic Effects of Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts.
Lu-DOTA-M5A与热休克蛋白90抑制剂奥纳司匹联合应用对结直肠癌异种移植瘤的治疗效果增强
Cancers (Basel). 2023 Aug 24;15(17):4239. doi: 10.3390/cancers15174239.
4
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling.基于肽的正电子发射断层扫描探针:合成与放射性标记的当前策略
RSC Med Chem. 2023 Jan 6;14(4):592-623. doi: 10.1039/d2md00397j. eCollection 2023 Apr 26.
5
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model.用225Ac进行碳酸酐酶IX靶向α放射性核素治疗可抑制肾细胞癌模型中的肿瘤生长。
Pharmaceuticals (Basel). 2022 May 2;15(5):570. doi: 10.3390/ph15050570.
6
Characterization of Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.镥-多胺多羧基大环配体- M5A抗癌胚抗原人源化抗体的表征及HSP90抑制用于增强结直肠癌的放射免疫治疗
Front Oncol. 2022 Mar 31;12:849338. doi: 10.3389/fonc.2022.849338. eCollection 2022.
7
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model.对比 CD38 靶向 α-与β-放射性核素疗法治疗多发性骨髓瘤在动物模型中的应用。
J Nucl Med. 2021 Jun 1;62(6):795-801. doi: 10.2967/jnumed.120.251983. Epub 2020 Oct 30.
8
Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of Lu- and Y-Rituximab in Xenografted Mice.DOTA螯合剂对异种移植小鼠体内镥标记和钇标记利妥昔单抗的放射化学纯度及生物分布的影响
Iran J Pharm Res. 2018 Fall;17(4):1201-1208.
9
Biodistribution and Lymphatic Tracking of the Main Neurotoxin of Micrurus fulvius Venom by Molecular Imaging.通过分子成像对珊瑚蛇毒液主要神经毒素的生物分布和淋巴追踪
Toxins (Basel). 2016 Mar 26;8(4):85. doi: 10.3390/toxins8040085.
10
Stability analysis of an inline peptide-based conjugate for metal delivery: nickel(II)-claMP Tag epidermal growth factor as a model system.用于金属递送的基于肽的直链缀合物的稳定性分析:以镍(II)-claMP标签表皮生长因子为模型系统。
J Pharm Sci. 2015 Feb;104(2):416-23. doi: 10.1002/jps.24132. Epub 2014 Sep 11.